Page 3 - Neil Maresky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Psyence Biomedical to List on Nasdaq Jan 26

By Stephen Nakrosis Psyence Biomedical said its shares would list on the Nasdaq, following its business combination with blank check company Newcourt.

United statesPsyence biomedNeil mareskyStephen nakrosisPsyence groupNorth americaArticle normalHealthcare life sciencesPrescription drugsCorporate changesStock listingsOwnership changesAcquisitions mergers shareholdingsAcquisitions mergersCorporate actionsCorporate industrial news

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCommonwealth of australiaPsyence biomedNeil mareskyPsyence group incCanadian securities exchangeNewcourt acquisition corpPsyence biomed divisionPsyence groupPurpose acquisition companyNgenu pty ltdPsyence biomedical ltdBusiness combination agreementNewcourt acquisitionBusiness combination

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCommonwealth of australiaNeil mareskyPsyence biomedPsyence biomedical ltd biomedCanadian securities exchangePsyence biomed divisionNewcourt acquisition corpPsyence groupPty ltdPsyence group incPurpose acquisition companyGroup incPsyence biomedical ltdBusiness combination

Psyence Group Inc Subsidiary Psyence Biomedical Ltd announces signing of definitive agreement for a convertible note in connection with planned business combination

TORONTO, Jan. 16, 2024 Psyence Group Inc , a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, today announced.

United statesUnited kingdomNeil mareskyPsyence biomedNewcourt acquisition companyPsyence biomedical ltd pubcoPsyence biomed divisionNewcourt acquisition corp nasdaqPsyence groupPsyence group incPurpose acquisition companyEllenoff grossman scholeCanadian securities exchangeGroup incPsyence biomedical ltdNote financing

Psyence Group Inc Subsidiary Psyence Biomedical Ltd

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) Psyence Group Inc (

United kingdomUnited statesPsyence biomedNeil mareskyPsyence group incCanadian securities exchangeEllenoff grossman scholePsyence biomedical ltd pubcoPsyence biomed divisionNewcourt acquisition corp nasdaqPsyence groupGroup incPsyence biomedical ltdNote financingNewcourt acquisition corpSecurities purchase agreement